781357853	781357853	CD	B-NP	O
|	|	NN	I-NP	O
SHO	SHO	NN	I-NP	O
|	|	NN	I-NP	O
43498648	43498648	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5603758	5603758	CD	B-NP	O
|	|	CC	I-NP	O
5/7/2004	5/7/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/24/2004	9/24/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/10/2004	4/10/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
KINDLER	KINDLER	NN	B-NP	O
,	,	,	O	O
ISIAH	ISIAH	NN	B-NP	O
322-13-75-2	322-13-75-2	CD	I-NP	O
Leah	Leah	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
7/15/04	7/15/04	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ARVELO	ARVELO	NNP	B-NP	O
,	,	,	O	O
DORSEY	DORSEY	NNP	B-NP	O
DICK	DICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ROCALTROL	ROCALTROL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCITRIOL	CALCITRIOL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.25	0.25	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QMWF	QMWF	NNP	I-NP	O
PHOSLO	PHOSLO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
ACETATE	ACETATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
667	667	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
CLONIDINE	CLONIDINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
0.1	0.1	CD	I-NP	O
MG/DAY	MG/DAY	NN	I-NP	O
TP	TP	NN	I-NP	O
Q168H	Q168H	NN	I-NP	O
PROCRIT	PROCRIT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EPOETIN	EPOETIN	NN	I-NP	O
ALFA	ALFA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
ordering	order	VBG	B-VP	O
:	:	:	O	O
Renal	Renal	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
Last	Last	JJ	I-NP	O
known	know	VBN	I-NP	O
Hgb	Hgb	NN	I-NP	B-protein
level	level	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
order	order	NN	B-NP	O
:	:	:	O	O
10.3	10.3	CD	B-NP	O
g/dL	g/dL	NN	I-NP	O
on	on	IN	B-PP	O
3/20/04	3/20/04	CD	B-NP	O
at	at	IN	B-PP	O
MH	MH	NN	B-NP	O
Symptoms	Symptom	NNS	I-NP	O
:	:	:	O	O
Fatigue	Fatigue	NN	B-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
Diagnosis	Diagnosis	NN	B-NP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
Renal	Renal	JJ	I-NP	O
Failure	Failure	NN	I-NP	O
873	873	CD	I-NP	O
Treatment	Treatment	NN	I-NP	O
Cycle	Cycle	NN	I-NP	O
:	:	:	O	O
Initiation	Initiation	NN	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
September	September	NNP	I-NP	O
LABETALOL	LABETALOL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
800	800	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	JJR	B-NP	O
90	90	CD	I-NP	O
or	or	CC	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
MUPIROCIN	MUPIROCIN	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	I-VP	O
shin	shin	VB	I-VP	O
NIFEREX-150	NIFEREX-150	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
MVI	MVI	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/11/04	6/11/04	CD	B-NP	O
by	by	IN	B-PP	O
STUTHEIT	STUTHEIT	NN	B-NP	O
,	,	,	O	O
BRENTON	BRENTON	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
51110663	51110663	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/11/04	6/11/04	CD	B-NP	O
by	by	IN	B-PP	O
HACKERD	HACKERD	NN	B-NP	O
,	,	,	O	O
STAN	STAN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

IMDUR	IMDUR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONIT	MONONIT	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
360	360	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
October	October	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
FLOVENT	FLOVENT	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FLUTICASONE	FLUTICASONE	NN	I-NP	I-protein
PROPIONATE	PROPIONATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
110	110	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LAMICTAL	LAMICTAL	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LAMOTRIGINE	LAMOTRIGINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
TRILEPTAL	TRILEPTAL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OXCARBAZEPINE	OXCARBAZEPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
46	46	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
April	April	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
half	half	PDT	B-NP	O
his	his	PRP$	I-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
PROTONIX	PROTONIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Toedebusch	Toedebusch	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PMD	PMD	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
January	January	NNP	I-NP	O
@	@	VBD	B-VP	O
1	1	CD	B-NP	O
:	:	SYM	O	O
30	30	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Callabrass	Callabrass	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Kidney	Kidney	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
March	March	NNP	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Katsaounis	Katsaounis	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
January	January	NNP	I-NP	O
@	@	.	O	O
4	4	CD	B-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Tape	Tape	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
bipolar	bipolar	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
bipolar	bipolar	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
panic	panic	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
panic	panic	NN	I-NP	O
disorder	disorder	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
copd	copd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
nephrotic	nephrotic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
nephrotic	nephrotic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
IV	IV	CD	I-NP	O
diuretics	diuretic	NNS	I-NP	O
,	,	,	O	O
vein	vein	NN	B-NP	O
graft	graft	NN	I-NP	O
mapping	map	VBG	B-VP	O
BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
64	64	CD	B-NP	O
y/o	y/o	NN	I-NP	O
male	male	JJ	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
nephrotic	nephrotic	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
DM2	DM2	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
bipolar	bipolar	JJ	B-NP	O
d/o	d/o	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
stent	stent	NN	I-NP	O
of	of	IN	B-PP	O
PDA	PDA	NN	B-NP	B-protein
in	in	IN	B-PP	O
8/10	8/10	CD	B-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
DOE	DOE	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
burning	burning	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
5/9	5/9	CD	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
doing	do	VBG	B-VP	O
baseline	baseline	NN	B-NP	O
after	after	IN	B-PP	O
d/c	d/c	NN	B-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
hotdogs	hotdog	NNS	B-NP	O
with	with	IN	B-PP	O
beans	bean	NNS	B-NP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
symptom	symptom	NN	B-NP	O
onset	onset	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
1/5	1/5	CD	B-NP	O
blocks	block	NNS	I-NP	O
walk	walk	VBP	B-VP	O
to	to	TO	I-VP	O
DOE	DOE	VB	I-VP	O
with	with	IN	B-PP	O
shaving	shave	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Burning	Burning	NN	B-NP	O
in	in	IN	B-PP	O
chest	chest	NN	B-NP	O
with	with	IN	B-PP	O
activity	activity	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
band	band	NN	I-NP	O
like	like	IN	B-PP	O
,	,	,	O	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
both	both	DT	B-NP	O
shoulders	shoulder	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
releived	releive	VBD	B-VP	O
promptly	promptly	RB	B-ADVP	O
with	with	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
in	in	IN	B-PP	O
11/18	11/18	CD	B-NP	O
stening	stening	NN	I-NP	O
of	of	IN	B-PP	O
PDA	PDA	NN	B-NP	B-protein
,	,	,	O	O
LAD	LAD	NN	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LCx	LCx	NN	B-NP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Stress	Stress	NN	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
11/1	11/1	CD	B-NP	O
-	-	HYPH	I-NP	O
55	55	CD	I-NP	O
%	%	NN	I-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
atypical	atypical	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
with	with	IN	B-PP	O
infusion	infusion	NN	B-NP	O
.	.	.	O	O

Vitals	Vital	NNS	B-NP	O
HR	HR	NN	I-NP	B-protein
80	80	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
155/90	155/90	CD	I-NP	I-DNA
,	,	,	O	O
Afebrile	Afebrile	NNP	B-NP	O
,	,	,	O	O
RR	RR	NNP	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

Gen	Gen	NNP	B-NP	O
:	:	:	O	O
Sitting	Sitting	NNP	B-NP	O
,	,	,	O	O
labored	labor	VBD	B-VP	O
breathing	breathing	NN	B-NP	O
Heent	Heent	NNP	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
10-11	10-11	CD	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruis	bruis	NN	I-NP	O
,	,	,	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
s3	s3	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
?	?	.	O	O

split	split	JJ	B-NP	O
s2	s2	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
SEm	SEm	NNP	I-NP	O
LUSB	LUSB	NNP	I-NP	O
,	,	,	O	O
Pulm	Pulm	NNP	B-NP	O
:	:	:	O	O
Rales	Rales	NNP	B-NP	O
diffuse	diffuse	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
BS	BS	NNP	B-NP	B-protein
LL	LL	NNP	I-NP	I-protein
bases	base	NNS	I-NP	I-protein
,	,	,	O	O
egophany	egophany	DT	O	O
on	on	IN	B-PP	O
R	R	NN	B-NP	B-protein
lower	low	JJR	I-NP	O
base	base	NN	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	O	O
+	+	SYM	O	O
BS	BS	NNP	B-NP	O
,	,	,	O	O
ext	ext	RB	B-ADVP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pit	pit	NN	I-NP	O
edema	edema	NN	I-NP	O
bilat	bilat	NN	I-NP	O
-	-	HYPH	B-NP	O
good	good	JJ	I-NP	O
DP/s	DP/	NNS	I-NP	O
WWp	WWp	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
anterior	anterior	JJ	B-NP	O
shin	shin	NN	I-NP	O
transdermal	transdermal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
new	new	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

**************	**************	SYM	O	O
Hospital	Hospital	NN	B-NP	O
Course	Course	NN	I-NP	O
***************	***************	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ISCHEMIA	ISCHEMIA	NN	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
with	with	IN	B-PP	O
prior	prior	JJ	B-NP	O
CAD/stent	CAD/stent	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
angina	angina	NN	I-NP	O
2nd	2nd	NN	I-NP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
decompenasted	decompenaste	VBN	B-NP	O
HF	HF	NN	I-NP	B-protein
.	.	.	O	O

cont	cont	JJ	B-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
not	not	RB	O	O
on	on	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Doubt	Doubt	NN	B-NP	O
primary	primary	JJ	I-NP	O
angina	angina	NN	I-NP	O
as	as	IN	B-PP	O
couse	couse	NN	B-NP	O
of	of	IN	B-PP	O
CHF/RHF	CHF/RHF	NN	B-NP	B-protein
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
?	?	.	O	O

dyastolic	dyastolic	JJ	B-NP	O
HF	HF	NN	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
decomp/exacerbation	decomp/exacerbation	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
with	with	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
-RRB-	-RRB-	SYM	O	O
-	-	HYPH	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
as	as	IN	B-PP	O
poss	poss	JJ	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Change	Change	NN	B-NP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	CD	I-NP	O
100	100	CD	I-NP	O
BID	BID	NN	I-NP	O
and	and	CC	O	O
strict	strict	JJ	B-NP	O
I/Os	I/O	NNS	I-NP	O
,	,	,	O	O
weights	weight	NNS	B-NP	O
.	.	.	O	O

October	October	NNP	B-NP	O
Pt	Pt	NNP	I-NP	O
has	have	VBZ	B-VP	O
responded	respond	VBN	I-VP	O
to	to	TO	B-PP	O
BMP	BMP	NN	B-NP	O
diuresis	diuresis	NN	I-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
.	.	.	O	O

Restarted	Restart	VBN	B-VP	O
here	here	RB	B-ADVP	O
on	on	IN	B-PP	O
BMP	BMP	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-VP	O
limited	limited	JJ	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
achieved	achieve	VBD	B-VP	O
-500	-500	CD	B-NP	O
ml	ml	NN	I-NP	O
qd	qd	NN	I-NP	O
but	but	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
suspect	suspect	VBP	B-VP	O
that	that	IN	B-SBAR	O
fluids	fluid	NNS	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
being	be	VBG	I-VP	O
acc	acc	NN	B-NP	O
urately	urately	RB	B-ADVP	O
accounted	account	VBD	B-VP	O
for	for	IN	B-PP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
being	be	VBG	I-VP	O
effect	effect	NN	B-NP	O
ively	ively	RB	B-VP	O
diuresed	diurese	VBN	I-VP	O
and	and	CC	O	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
RHYTHM	RHYTHM	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
arhtymias	arhtymia	NNS	B-NP	B-protein
4	4	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
RENAL	RENAL	NN	I-NP	O
:	:	:	O	O
PT	PT	NN	B-NP	O
with	with	IN	B-PP	O
stage	stage	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
CRI	CRI	NN	I-NP	I-protein
and	and	CC	O	O
nephrotic	nephrotic	JJ	B-NP	O
synd	synd	NN	I-NP	O
.	.	.	O	O

May	May	MD	B-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overload	overload	RB	B-ADVP	O
2nd	2nd	CD	B-NP	O
to	to	TO	B-PP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	O
decomp/exacer	decomp/exacer	NN	I-NP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
but	but	CC	O	O
elevated	elevate	VBD	B-VP	O
to	to	TO	B-PP	O
5.3	5.3	CD	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
Pt	Pt	NNP	B-NP	O
's	's	POS	B-NP	O
current	current	JJ	I-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
dialysis	dialysis	NN	B-NP	O
seems	seem	VBZ	B-VP	O
imminent	imminent	JJ	B-ADJP	O
.	.	.	O	O

October	October	NNP	B-NP	O
Pt	Pt	NNP	I-NP	O
went	go	VBD	B-VP	O
for	for	IN	B-PP	O
vein	vein	NN	B-NP	O
mapping	mapping	NN	I-NP	O
but	but	CC	O	O
pt	pt	NN	B-NP	O
remained	remain	VBD	B-VP	O
uncertain	uncertain	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
accept	accept	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
treatment	treatment	NN	I-NP	O
option	option	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
creatnine	creatnine	NN	I-NP	O
now	now	RB	B-ADVP	O
5.0	5.0	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
creatnine	creatnine	NN	B-NP	O
checked	check	VBN	B-VP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
called	call	VBD	B-VP	O
in	in	RP	B-PRT	O
to	to	TO	B-PP	O
following	follow	VBG	B-PP	O
physician	physician	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
HD	HD	VB	I-VP	O
plan	plan	NN	B-NP	O
accordingly	accordingly	RB	B-ADVP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
,	,	,	O	O
Guaiac	Guaiac	JJ	B-NP	O
neg	neg	NN	I-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
DM2	DM2	NN	B-NP	B-protein
-	-	HYPH	O	O
will	will	NN	B-NP	O
on	on	IN	B-PP	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
lantus	lantus	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
with	with	IN	B-PP	O
RISS	RISS	NN	B-NP	B-protein
,	,	,	O	O
HA1C-5	HA1C-5	NN	B-NP	O
.7	.7	CD	I-NP	O
subclinical	subclinical	JJ	I-NP	O
hypothyroid	hypothyroid	NN	I-NP	O
,	,	,	O	O
TSH-3	TSH-3	NN	B-NP	O
.235	.235	CD	I-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HEME	HEME	NN	I-NP	B-protein
:	:	:	O	O
microcytic	microcytic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
?	?	.	O	O

FE	FE	NN	B-NP	O
vs.	vs.	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
with	with	IN	B-PP	O
transfusion	transfusion	NN	B-NP	O
from	from	IN	B-PP	O
ED	ED	JJ	B-NP	O
,	,	,	I-NP	O
unable	unable	JJ	I-NP	O
to	to	TO	B-VP	O
send	send	VB	I-VP	O
FE	FE	NNP	B-NP	O
studies	study	NNS	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
Procrit	Procrit	NN	B-NP	O
per	per	IN	B-PP	O
renal	renal	JJ	B-ADJP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
PSYCH	PSYCH	NN	I-NP	O
:	:	:	O	O
Bipolar	Bipolar	JJ	B-NP	O
d/o	d/o	AFX	I-NP	O
-	-	HYPH	I-NP	O
cont	cont	NN	B-NP	O
meds	med	NNS	I-NP	O
9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Pt	Pt	NN	I-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
poor	poor	JJ	I-NP	O
ox	ox	NN	I-NP	O
sat	sat	NN	I-NP	O
-	-	HYPH	B-NP	O
f/u	f/u	NN	I-NP	O
CT	CT	NN	I-NP	O
for	for	IN	B-PP	O
structural	structural	JJ	B-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
oxygenation	oxygenation	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FULL	FULL	NNP	I-NP	O
Code	Code	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
note	note	VBP	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
made	make	VBN	I-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
changes	change	NNS	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Simvostatin	Simvostatin	NN	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
now	now	RB	B-ADVP	O
40	40	CD	B-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
180	180	CD	B-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
Rocaltrol	Rocaltrol	NN	B-NP	O
m/w/f	m/w/f	NN	I-NP	O
;	;	:	O	O
phoslo	phoslo	NN	B-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
procrit	procrit	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
administered	administer	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Vosburgh	Vosburgh	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Mupirocin	Mupirocin	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
apply	apply	VB	B-VP	O
to	to	TO	I-VP	O
open	open	VB	I-VP	O
soar	soar	JJ	B-NP	O
2x/day	2x/day	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
please	please	VB	B-VP	O
return	return	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
excessive	excessive	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
weigh	weigh	VB	I-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
losing	lose	VBG	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
kg/day	kg/day	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
2.2	2.2	CD	B-NP	O
lbs	lb	NNS	I-NP	O
-RRB-	-RRB-	MD	B-VP	O
skip	skip	VB	I-VP	O
your	your	PRP$	B-NP	O
evening	evening	NN	I-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Make	Make	VB	B-VP	O
sure	sure	JJ	B-ADJP	O
you	you	PRP	B-NP	O
get	get	VBP	B-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
drawn	draw	VBN	B-VP	O
before	before	IN	B-PP	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
CHF	CHF	NN	I-NP	O
appointment	appointment	NN	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
pm	pm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MCCREARY	MCCREARY	NNP	B-NP	O
,	,	,	O	O
ARNULFO	ARNULFO	NNP	B-NP	O
SAUL	SAUL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LI615	LI615	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/15/04	7/15/04	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
06	06	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

